跳至主要内容
临床试验/NCT01899391
NCT01899391撤回不适用

A Pilot Study of Gamma H2AX DNA Repair Foci Kinetics in Peripheral Blood Lymphocytes During Prostate Cancer Radiotherapy

University Health Network, Toronto0 个研究点开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Gamma H2AX in peripheral blood lymphocytes.

研究概览

简要总结

Right now it is not possible to predict which patients are going to react more to RT. Many things could affect patient's response to radiation. One of the factors is whether the person can repair damage to the genetic material (DNA/RNA) caused by the RT. There is some evidence that a certain protein called Gamma H2AX is involved in DNA damage and repair and this can be used to predict the sensitivity of individual patients. The investigators will be studying this protein: Gamma H2AX) in the blood samples of prostate cancer patients exposed to both computed tomography (CT) scan and RT treatment. This will help us to understand why different individuals show differences in side effects following RT.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Intermediate-risk prostate cancer patients (T1/T2N0M0 with either GS < 7 and PSA between 10-20 ng/ml or GS 7 and PSA less than 20 ng/ml).
  • Planned for radical RT to the prostate with IMRT planning (79Gy/39fractions or 60 Gy/20 fractions).
  • No contraindications to diagnostic CT scanning.
  • Prostate volumes will be less than 80 cc to control the planning dose volume histogram (DVH) as much as possible in terms of rectal and bladder volumes.
  • No known DNA repair disorders (e.g. family history of AT, BRCA1/2 or Li Fraumeni syndrome) or contraindications to radical pelvic RT.

排除标准

  • Inability to provide informed consent.
  • Patient having contraindications to diagnostic CT scan.
  • Patients who have unobtainable data regarding previous therapy and their clinical outcome.
  • Patients should not have any diagnostic X-rays or CAT scans 2 weeks prior to their enrollment into the study.

结局指标

主要结局

Gamma H2AX in peripheral blood lymphocytes.

时间窗: 1 year

次要结局

  • Gamma H2AX following RT planning (CT scan).(1 year)
  • Gamma H2AX during RT(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Periperal Blood Lymphocytes During Prostate RT | 临床试验